UPDATE 2-AstraZeneca Imfinzi combination fails advanced lung cancer study By: Reuters: Company News August 21, 2019 at 07:35 AM EDT * Trial studied treatment in patients whose cancer had spread Read More >> Related Stocks: Astrazeneca Plc ADR Bristol-Myers Squibb Merck & Co